Enjoy the event with subtitles available in multiple languages. *Subtitles are AI-generated and may contain inaccuracies.
close
This content is not available in your location
This event is scheduled for
Only logged in users can watch the content
To access AIS Channel content, please allow all cookies. Please click here to configure your preferences.
Sacral Neuromodulation for Bladder and Bowel Management
Medtronic
Share
share
Dec, 2023
Chat
keyboard_arrow_down
Description
keyboard_arrow_down
Fecal incontinence and Overactive Bladder are very prevalent disabling disorders. A plethora of therapeutic options have been attempted without universal acceptance due to suboptimal results. Sacral neuromodulation (SNM) has become widely globally accepted as a very effective safe option for the treatment of both fecal incontinence and overactive bladder. In addition, this technology is the only practical therapy that can treat Idiopathic Urinary Retention. This program combines the expertise of both colorectal surgeons and urologists to share their expertise and insights about the role of SNM within the spectrum of available therapeutic options for these conditions. Optimal outcomes in both high and low-resource environments will be described and best practice methods to help ensure maximum efficacy will be evaluated.
Welcome & Introduction - Dr. Howard B. Goldman (USA) and Dr. Steven D. Wexner (USA)
Background on OAB and non-obstructive urinary retention - Dr. Una Lee (USA)
Traditional Treatment - OAB - Dr. Marcio Averbeck (Brazil)
Role of SNM for OAB - Prof. Dr. Hashim Hashim (UK)
Why SNM is the procedure of choice for fecal incontinence? - Dr. Brooke Gurland (USA)
Troubleshooting for success - Dr. Anna Spivak (USA)
Optimizing outcomes in low resource environments - Dr. Lucía Oliveira (Brazil)
Panel discussion - All faculty moderated by Dr. Howard B. Goldman (USA) and Dr. Steven D. Wexner (USA)
Closing remarks - Dr. Howard B. Goldman (USA) and Dr. Steven D. Wexner (USA)